Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. 2004

Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
Department of Cell Biology and Molecular Medicine, New Jersey Medical Scchool, University of Medicine and Dentistry of New Jeresy, Newark 07101-1709, USA. kawabeju@khaki.plala.or.jp

Mechanical stress contributes to vascular disease related to hypertension. Activation of ERK is key to mediating cellular proliferation and vascular remodeling in response to stretch stress. However, the mechanism by which stretch mediates ERK activation in the vascular tissue is still unclear. Caveolin, a major component of a flasklike invaginated caveolae, acts as an adaptor protein for an integrin-mediated signaling pathway. We found that cyclic stretch transiently induced translocation of caveolin from caveolae to noncaveolar membrane sites in vascular smooth muscle cells (VSMCs). This translocation of caveolin was determined by detergent solubility, sucrose gradient fractionation, and immunocytochemistry. Cyclic stretch induced ERK activation; the activity peaked at 5 min (the early phase), decreased gradually, but persisted up to 120 min (the late phase). Disruption of caveolae by methyl-beta-cyclodextrin, decreasing the caveolar caveolin and accumulating the noncaveolar caveolin, enhanced ERK activation in both the early and late phases. When endogenous caveolins were downregulated, however, the late-phase ERK activation was subsided completely. Caveolin, which was translocated to noncaveolar sites in response to stretch, is associated with beta1-integrins as well as with Fyn and Shc, components required for ERK activation. Taken together, caveolin in caveolae may keep ERK inactive, but when caveolin is translocated to noncaveolar sites in response to stretch stress, caveolin mediates stretch-induced ERK activation through an association with beta1-integrins/Fyn/Shc. We suggest that stretch-induced translocation of caveolin to noncaveolar sites plays an important role in mediating stretch-induced ERK activation in VSMCs.

UI MeSH Term Description Entries
D008841 Actin Cytoskeleton Fibers composed of MICROFILAMENT PROTEINS, which are predominately ACTIN. They are the smallest of the cytoskeletal filaments. Actin Filaments,Microfilaments,Actin Microfilaments,Actin Cytoskeletons,Actin Filament,Actin Microfilament,Cytoskeleton, Actin,Cytoskeletons, Actin,Filament, Actin,Filaments, Actin,Microfilament,Microfilament, Actin,Microfilaments, Actin
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D000071425 Src Homology 2 Domain-Containing, Transforming Protein 1 An SHC-signaling adaptor protein that transduces PHOSPHOTYROSINE-dependent signals downstream of RECEPTOR PROTEIN-TYROSINE KINASES and non-receptor tyrosine kinases. It is required for TGF-BETA-induced CELL MIGRATION; NEOLPASM INVASION; and METASTASIS of BREAST NEOPLASMS; its SH2 DOMAIN is essential for tumor survival. It also functions in signaling downstream of ANGIOPOIETIN RECEPTOR TIE-2, regulating the migration of ENDOTHELIAL CELLS; and PHYSIOLOGIC NEOVASCULARIZATION. SHC (Src Homology 2 Domain-Containing) Transforming Protein 1,SHC-Transforming Protein 1,SHC1 (Src Homology 2 Domain-Containing) Protein,SHC1 Protein,ShcA Protein,Src Homology 2 Domain-Containing-Transforming Protein C1,SHC Transforming Protein 1,Src Homology 2 Domain Containing Transforming Protein C1,Src Homology 2 Domain Containing, Transforming Protein 1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities

Related Publications

Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
January 2004, American journal of physiology. Heart and circulatory physiology,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
October 2008, Biochemical and biophysical research communications,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
April 1999, The American journal of physiology,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
October 1992, The American journal of physiology,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
August 2007, American journal of physiology. Lung cellular and molecular physiology,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
May 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
March 2019, Experimental cell research,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
February 2012, IUBMB life,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
May 2008, Biochemical and biophysical research communications,
Jun-ichi Kawabe, and Satoshi Okumura, and Ming-Chih Lee, and Junichi Sadoshima, and Yoshihiro Ishikawa
February 2016, FEBS letters,
Copied contents to your clipboard!